Angelini Labopharm Overview

  • Founded
  • 2010
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 1,001
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Angelini Labopharm General Information

Description

Distributor of pharmaceutical products. The company is engaged the commercialization and distribution of OLEPTRO™ drug to treat depression among adults.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale (B2C)
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Angelini
Primary Office
  • 202 Carnegie Center
  • Suite 107
  • Princeton, NJ 08540
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Angelini Labopharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Angelini Labopharm‘s full profile, request access.

Request a free trial

Angelini Labopharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angelini Labopharm Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Angelini Labopharm‘s full profile, request access.

Request a free trial